Davide Campari-Milano SpA (CPR) Stock Forecast & Price Target

Compare

66 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

CPR Analyst Ratings

Hold

3 Buy

5 Hold

1 Sell

Based on 9 analysts giving stock ratings to

Davide

Campari-Milano SpA

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

CPR Stock 12 Month Forecast

Average Price Target

€6.87

▲(12.62%Upside)

Based on 9 Wall Street analysts offering 12 month price targets for Davide Campari-Milano SpA in the last 3 months. The average price target is €6.87 with a high forecast of €10.50 and a low forecast of €5.60. The average price target represents a 12.62% change from the last price of €6.10.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"4":"€4","11":"€11","5.75":"€5.75","7.5":"€7.5","9.25":"€9.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":10.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€10.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":6.87,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€6.87</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":5.6,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€5.60</span>\n  </div></div>","useHTML":true}}],"tickPositions":[4,5.75,7.5,9.25,11],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2024","6":"Jan<br/>2025","9":"Apr<br/>2025","12":"Jul<br/>2025","25":"Jul<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5.906,6.259384615384615,6.6127692307692305,6.966153846153846,7.319538461538461,7.672923076923077,8.026307692307693,8.379692307692308,8.733076923076922,9.086461538461538,9.439846153846155,9.79323076923077,10.146615384615384,{"y":10.5,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5.906,5.980153846153846,6.054307692307692,6.128461538461538,6.202615384615385,6.27676923076923,6.350923076923077,6.425076923076923,6.499230769230769,6.573384615384615,6.647538461538462,6.721692307692308,6.795846153846154,{"y":6.87,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5.906,5.882461538461538,5.858923076923077,5.835384615384615,5.811846153846154,5.788307692307692,5.764769230769231,5.741230769230769,5.717692307692308,5.694153846153846,5.670615384615385,5.647076923076923,5.623538461538461,{"y":5.6,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":8.583,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.055,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.277,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.512,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.126,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.744,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.029,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.523,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.659,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.424,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.884,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.596,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.906,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€10.50

Average Price Target€6.87

Lowest Price Target€5.60

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

TipRanks AITipRanks

Not Ranked

TipRanks

€6

Hold

-1.64%

Downside

Reiterated

07/01/25

The stock's score is primarily driven by its strong financial performance, with solid revenue growth and improving cash flow metrics. However, challenges such as declining net profitability, high leverage, and a high P/E ratio limit its overall attractiveness. The technical analysis indicates neutral momentum, and the valuation suggests the stock may be overvalued. These factors combined result in a moderate overall stock score.

Richard WithagenKepler Capital

Kepler Capital

€7.2

Buy

18.03%

Upside

Reiterated

07/08/25

Davide Campari-Milano SpA (58H) Receives a Buy from Kepler Capital

Sanjeet AujlaUBS

UBS

€5.7→€6

Hold

-1.64%

Downside

Reiterated

06/30/25

UBS Keeps Their Hold Rating on Davide Campari-Milano SpA (58H)

Simon HalesCiti

Citi

€7.25→€7

Buy

14.75%

Upside

Reiterated

06/27/25

Davide Campari-Milano SpA (58H) Gets a Buy from Citi

Trevor StirlingBernstein

Bernstein

€11→€10.5

Buy

72.13%

Upside

Reiterated

06/26/25

Davide Campari-Milano SpA (58H) Gets a Buy from Bernstein

Mitch CollettDeutsche Bank

Deutsche Bank

€5.9→€5.7

Hold

-6.56%

Downside

Reiterated

06/24/25

Deutsche Bank Sticks to Its Hold Rating for Davide Campari-Milano SpA (58H)

Calum CellarnoxAI Firm

AI Firm

€6

Hold

-1.64%

Downside

Reiterated

06/22/25

Unknown AnalystBerenberg Bank

Not Ranked

Berenberg Bank

€6.3

Hold

3.28%

Upside

Reiterated

05/13/25

James Edwardes JonesRBC Capital

RBC Capital

€5.9→€5.6

Sell

-8.20%

Downside

Reiterated

05/09/25

RBC Capital Sticks to Their Sell Rating for Davide Campari-Milano SpA (58H)

Laurence WhyattBarclays

Barclays

€7.2→€7.5

Hold

22.95%

Upside

Reiterated

04/11/25

Davide Campari-Milano SpA (58H) Receives a Hold from Barclays

Cedric LecasbleStifel Nicolaus

Stifel Nicolaus

€9→€8.5

Buy

39.34%

Upside

Reiterated

03/11/25

Davide Campari-Milano Spa (CPR:IM) PT Lowered to EUR8.50 at StifelStifel analyst Cedric Lecasble lowered the price target on Davide Campari-Milano Spa (CPR:IM) to EUR8.50 (from EUR9.00) while maintaining a Buy rating.

Ed MundyJefferies

Jefferies

€6.6

Hold

8.20%

Upside

Reiterated

03/07/25

Jefferies Sticks to Its Hold Rating for Davide Campari-Milano SpA (58H)

Unknown AnalystGoldman Sachs

Not Ranked

Goldman Sachs

€8.5→€7.5

Hold

22.95%

Upside

Reiterated

03/05/25

Andrea PistacchiBank of America Securities

Bank of America Securities

€8.5→€6.3

Hold

3.28%

Upside

Downgraded

01/14/25

BofA Securities Downgrades Davide Campari-Milano Spa (CPR:IM) to NeutralBofA Securities analyst Andrea Pistacchi downgraded Davide Campari-Milano Spa (CPR:IM) from Buy to Neutral with a price target of EUR6.30 (from EUR8.50).

Jeremy FialkoHSBC

HSBC

€8.7

Buy

42.62%

Upside

Reiterated

12/23/24

HSBC Reiterates Buy Rating on Davide Campari-Milano Spa (CPR:IM)HSBC analyst Jeremy Fialko reiterated a Buy rating and EUR8.70 price target on Davide Campari-Milano Spa (CPR:IM).

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

TipRanks AITipRanks

Not Ranked

TipRanks

€6

Hold

-1.64%

Downside

Reiterated

07/01/25

Richard WithagenKepler Capital

Kepler Capital

€7.2

Buy

18.03%

Upside

Reiterated

07/08/25

Davide Campari-Milano SpA (58H) Receives a Buy from Kepler Capital

Sanjeet AujlaUBS

UBS

€5.7→€6

Hold

-1.64%

Downside

Reiterated

06/30/25

UBS Keeps Their Hold Rating on Davide Campari-Milano SpA (58H)

Simon HalesCiti

Citi

€7.25→€7

Buy

14.75%

Upside

Reiterated

06/27/25

Davide Campari-Milano SpA (58H) Gets a Buy from Citi

Trevor StirlingBernstein

Bernstein

€11→€10.5

Buy

72.13%

Upside

Reiterated

06/26/25

Davide Campari-Milano SpA (58H) Gets a Buy from Bernstein

Mitch CollettDeutsche Bank

Deutsche Bank

€5.9→€5.7

Hold

-6.56%

Downside

Reiterated

06/24/25

Deutsche Bank Sticks to Its Hold Rating for Davide Campari-Milano SpA (58H)

Calum CellarnoxAI Firm

AI Firm

€6

Hold

-1.64%

Downside

Reiterated

06/22/25

Unknown AnalystBerenberg Bank

Not Ranked

Berenberg Bank

€6.3

Hold

3.28%

Upside

Reiterated

05/13/25

James Edwardes JonesRBC Capital

RBC Capital

€5.9→€5.6

Sell

-8.20%

Downside

Reiterated

05/09/25

RBC Capital Sticks to Their Sell Rating for Davide Campari-Milano SpA (58H)

Laurence WhyattBarclays

Barclays

€7.2→€7.5

Hold

22.95%

Upside

Reiterated

04/11/25

Davide Campari-Milano SpA (58H) Receives a Hold from Barclays

Cedric LecasbleStifel Nicolaus

Stifel Nicolaus

€9→€8.5

Buy

39.34%

Upside

Reiterated

03/11/25

Ed MundyJefferies

Jefferies

€6.6

Hold

8.20%

Upside

Reiterated

03/07/25

Jefferies Sticks to Its Hold Rating for Davide Campari-Milano SpA (58H)

Unknown AnalystGoldman Sachs

Not Ranked

Goldman Sachs

€8.5→€7.5

Hold

22.95%

Upside

Reiterated

03/05/25

Andrea PistacchiBank of America Securities

Bank of America Securities

€8.5→€6.3

Hold

3.28%

Upside

Downgraded

01/14/25

Jeremy FialkoHSBC

HSBC

€8.7

Buy

42.62%

Upside

Reiterated

12/23/24

HSBC Reiterates Buy Rating on Davide Campari-Milano Spa (CPR:IM)HSBC analyst Jeremy Fialko reiterated a Buy rating and EUR8.70 price target on Davide Campari-Milano Spa (CPR:IM).

Stocks with the Highest Top Analyst Consensus in the Consumer Defensive Sector

xxx

Find stocks in the Consumer Defensive sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Davide Campari-Milano SpA

1 Month

xxx

Success Rate

9/11 ratings generated profit

Average Return

+4.54%

reiterated a xxx

rating 16 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 81.82% of your transactions generating a profit, with an average return of +4.54% per trade.

3 Months

xxx

Success Rate

8/11 ratings generated profit

Average Return

+4.05%

reiterated a xxx

rating 16 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 72.73% of your transactions generating a profit, with an average return of +4.05% per trade.

1 Year

Trevor StirlingBernstein

Success Rate

6/11 ratings generated profit

Average Return

-0.21%

reiterated a buy rating 16 days ago

Copying Trevor Stirling's trades and holding each position for 1 Year would result in 54.55% of your transactions generating a profit, with an average return of -0.21% per trade.

2 Years

xxx

Success Rate

6/11 ratings generated profit

Average Return

-9.27%

reiterated a xxx

rating 16 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 54.55% of your transactions generating a profit, with an average return of -9.27% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CPR Analyst Recommendation Trends

Rating

Mar 25

Apr 25

May 25

Jun 25

Jul 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, CPR has received 8 Buy Ratings, 8 Hold Ratings, and 1 Sell Ratings. CPR average Analyst price target in the past 3 months is 6.87.

Each month's total comprises the sum of three months' worth of ratings.

CPR Financial Forecast

CPR Earnings Forecast

Next quarter’s earnings estimate for CPR is €0.00 with a range of €0.00 to €0.00. The previous quarter’s EPS was ―. CPR beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 39.74% of the time in the same period. In the last calendar year CPR has Preformed in-line its overall industry.

CPR Sales Forecast

Next quarter’s sales forecast for CPR is €859.60M with a range of €826.00M to €883.50M. The previous quarter’s sales results were ―. CPR beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 51.38% of the time in the same period. In the last calendar year CPR has Outperformed its overall industry.

CPR Stock Forecast FAQ

What is IT:CPR’s average 12-month price target, according to analysts?

Based on analyst ratings, Davide Campari-Milano SpA’s 12-month average price target is 6.87.

What is IT:CPR’s upside potential, based on the analysts’ average price target?

Davide Campari-Milano SpA has 12.62% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Davide Campari-Milano SpA a Buy, Sell or Hold?

Davide Campari-Milano SpA has a consensus rating of Hold, which is based on 3 buy ratings, 5 hold ratings and 1 sell ratings.

What is Davide Campari-Milano SpA’s share price target?

The average share price target for Davide Campari-Milano SpA is 6.87. This is based on 9 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €10.50 ,and the lowest forecast is €5.60. The average share price target represents 12.62% Increase from the current price of €6.1.

What do analysts say about Davide Campari-Milano SpA?

Davide Campari-Milano SpA’s analyst rating consensus is a Hold. This is based on the ratings of 9 Wall Streets Analysts.

How can I buy shares of Davide Campari-Milano SpA?

To buy shares of IT:CPR, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Davide Campari-Milano SpA (CPR) Stock Forecast & Price Target

CPR Analyst Ratings

CPR Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Davide Campari-Milano SpA

CPR Analyst Recommendation Trends

CPR Financial Forecast

CPR Earnings Forecast

CPR Sales Forecast

CPR Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts